Leiser J, Blum J J
FEBS Lett. 1984 Aug 6;173(2):407-13. doi: 10.1016/0014-5793(84)80815-7.
The effects of vasoactive intestinal polypeptide (VIP) and of forskolin on alanine metabolism in hepatocytes isolated from fed and fasted rats were examined. VIP and 17 microM forskolin stimulated glucose production, gluconeogenesis from alanine, and ureagenesis, and inhibited glyconeogenesis to comparable degrees. However, combination of 17 microM forskolin with a maximal dose of VIP significantly augmented only the inhibition of glyconeogenesis. At 100 microM, forskolin induced metabolic responses comparable to those induced by glucagon, but similarly, in combination with maximal doses of VIP or glucagon, augmented only inhibition of glycogen synthesis. In addition to demonstrating modulation of alanine metabolism by VIP and forskolin, these results raise questions about the nature of the coupling between VIP receptor occupancy and metabolic response.
研究了血管活性肠肽(VIP)和福斯高林对从喂食和禁食大鼠分离的肝细胞中丙氨酸代谢的影响。VIP和17微摩尔福斯高林刺激葡萄糖生成、丙氨酸糖异生和尿素生成,并在相当程度上抑制糖原生成。然而,17微摩尔福斯高林与最大剂量的VIP联合使用仅显著增强了对糖原生成的抑制作用。在100微摩尔时,福斯高林诱导的代谢反应与胰高血糖素诱导的反应相当,但同样,与最大剂量的VIP或胰高血糖素联合使用时,仅增强了对糖原合成的抑制作用。除了证明VIP和福斯高林对丙氨酸代谢的调节作用外,这些结果还引发了关于VIP受体占据与代谢反应之间偶联性质的问题。